Anita Wagner

Anita Katharina Wagner, PharmD, MPH, DrPH

Fellow in Bioethics

Anita Katharina Wagner is Associate Professor in the Division of Health Policy and Insurance Research at the Department of Population Medicine at Harvard Medical School and the Harvard Pilgrim Health Care Institute. She also serves as the Director of the Harvard Pilgrim Health Care Ethics Program

Dr. Wagner conducts empirical research generating evidence for answering challenging health system questions.  Her work, frequently in large databases, evaluates impacts of insurance and other policy changes on the availability, access to, affordability, and use of medicines, specifically new cancer medicines, in the United States, China, and elsewhere.    

Through the Medicines and Insurance Coverage (MedIC) Initiative she founded, Dr. Wagner has led training programs, including the first online course, to strengthen capacity of professionals in more than 20 low and middle income country health systems to design, implement, monitor and evaluate medicines policies and programs in the context of expanding health insurance coverage.

Dr. Wagner co-directs the Harvard Medical School Fellowship in Health Policy and Insurance Research and the Department of Population Medicine Center for Cancer Policy and Program Evaluation (CarPE)

Serving as a pharmacoepidemiologist on the FDA’s Sentinel Initiative, Dr. Wagner contributes to a national system that tracks the safety of pharmaceuticals in the United States. 

Dr. Wagner holds a German master-equivalent degree in pharmacy, a doctorate in clinical pharmacy from the Massachusetts College of Pharmacy and Allied Health Sciences, a Master of Public Health degree in international health and a Doctor of Public Health degree in epidemiology from the Harvard School of Public Health. She completed training programs in bioethics including the Harvard Medical School Fellowship in Bioethics.

Publications View
The health status of adults with epilepsy compared with that of people without chronic conditions.
Authors: Authors: Wagner AK, Bungay KM, Kosinski M, Bromfield EB, Ehrenberg BL.
Pharmacotherapy
View full abstract on Pubmed
Assessing the health status of adult patients with epilepsy.
Authors: Authors: Wagner AK, Bungay KM, Bromfield EB, Ehrenberg BL.
Am J Health Syst Pharm
View full abstract on Pubmed
Introduction to pharmacist participation in measuring and monitoring patients' health-related quality of life.
Authors: Authors: Bungay KM, Wagner AK.
Am J Health Syst Pharm
View full abstract on Pubmed
The routine use of health-related quality of life measures in the care of patients with epilepsy: rationale and research agenda.
Authors: Authors: Wagner AK, Vickrey BG.
Qual Life Res
View full abstract on Pubmed
Advances in methods for assessing the impact of epilepsy and antiepileptic drug therapy on patients' health-related quality of life.
Authors: Authors: Wagner AK, Keller SD, Kosinski M, Baker GA, Jacoby A, Hsu MA, Chadwick DW, Ware JE.
Qual Life Res
View full abstract on Pubmed
Comment: assessing the quality of pharmaceutical care.
Authors: Authors: Bungay KM, Wagner AK.
Ann Pharmacother
View full abstract on Pubmed
Assessing the health-related quality of life of people with epilepsy
Authors: Authors: Wagner AK
International Epilepsy News
International Quality of Life Assessment (IQOLA)Project
Authors: Authors: Wagner AK
Quality of Life Newsletter
Costs of hospital care for hypertension in an insured population without an outpatient medicines benefit: an observational study in the Philippines
Authors: Authors: Wagner AK, Valera M, Graves AJ, Laviña S, Ross-Degnan D
BMC Health Serv Res
Using patient-based assessments for individual patient care
Authors: Authors: Wagner AK
Pharmacoeconomics and outcomes: Applications for patient care

Address: 
Harvard Pilgrim Health Care Institute
Landmark Center
401 Park Dr
Boston, MA 02215